Brain Energy Metabolism in Alzheimers Disease - Part A
- 1 Edición, Volumen 186 - 11 de junio de 2026
- Última edición
- Editor: Subashchandrabose Chinnathambi
- Idioma: Inglés
Brain Energy Metabolism in Alzheimer’s Disease – Part A, published as Volume 186 of the serial International Review of Neurobiology, provides a comprehensive and up‑to‑d… Leer más
Descripción
Descripción
Puntos claves
Puntos claves
- Integrates classical and emerging perspectives on brain energy metabolism in Alzheimer’s disease
- Highlights the role of mitochondrial dysfunction, redox imbalance, and neuronal senescence
- Explores environmental and systemic modifiers, including microplastics, PFAS, and gut microbiome dysbiosis
- Examines neurotransmitter metabolism, particularly glutamate–glutamine cycling, across neurodegenerative disorders
- Addresses regulatory mechanisms such as circadian rhythms and neurovascular coupling
- Provides translational insights with potential therapeutic avenues, including marine-derived bioactive compounds
De interès para
De interès para
- Neuroscientists and neurobiologists specialising in neurodegenerative diseases
- Alzheimer’s disease and dementia researchers
- Molecular and cellular biologists studying metabolism and mitochondria
- Neurologists and clinician-scientists with an interest in translational neurobiology
- Researchers in neurotoxicology, environmental health, and brain metabolism
- Advanced postgraduate students in neuroscience, biomedical sciences, and related disciplines
Índice
Índice
- Glutamate and Glutamine metabolism in Neurodegenerative diseases
Kesharthini Karthikeyan, Gowshika Velmurugan, Riddhi Upadhyay, Murugan Sevanan, and Subashchandrabose Chinnathambi
- Invisible Threats of Microplastics Induced Toxicity: Oxidative and Inflammatory Pathways in the CNS and Retina
- Avinash Shenoy, Taslima Akter Eva, Viswanthram Palanivel, Akanksha Salkar, Veer B Gupta, Nitin Chitranshi, Stuart L Graham, Vivek Gupta, and Devaraj Basavarajapp
- Redox Bioenergetics of Neuronal Senescence in Alzheimer's Disease
Erdem Atasever, Şeydanur Turgut, Gülnur Andican, and Ufuk Çakatay
- Glutamate-Glutamine Metabolism and Transport, Implications in Parkinson’s disease
Ragini Raghu and Subashchandrabose Chinnathambi
- Environmental Toxins, PFAS Exposure, and Brain Metabolism: A New Angle in Alzheimer’s Disease Pathophysiology
Vedika Jain and Sharda Bharti
- TMEM230 and Mitochondrial Regulation in Alzheimer’s Disease
Ileana Zucchi, Cinzia Cocola, Paride Pelucchi, Daniela Mazzaccaro, Giovanni Nano, Mira Palizban, Giovanni Porta, and Reinbold, A Rolland
- Mitochondrial Rescue in Alzheimer’s Disease: Exploring Marine-Derived Compounds for Brain Metabolism Regulation
Periyasamy Vijayalakshmi, Asha Monica Alex, Saravanan Muthupandian, Deepali Desai, Mani Jayaprakashvel, Sanjeev Kumar Singh, and Chandrabose Selvaraj
- Circadian rhythm, metabolic stress, and Alzheimer’s disease
Vaishali Saini, Siddharth Singh, Raunak Kumar, Md Shahadab, and Hem Chandra Jha
- Starved Synapses: Gut Microbiome Dysbiosis and Its Role in Alzheimer’s Glucose Impairment
Riddhi Upadhyay, Sneha Santhosh R. Malathi, P. Saravana Kumari, and Murugan Sevanan
- Starved Synapses: Gut Microbiome Dysbiosis and Its Role in Alzheimer’s Glucose Impairment
Carla Mariana da Silva Medeiros, Renata Santos Vieira da Conceição, Mikael Kélvin de Albuquerque Mendes, Jemmyson Romário de Jesus and Cícero Alves Lopes Júnior
- Neurovascular coupling and energy substrate delivery in Alzheimer’s diseas
Shivam Malviya, Debasmita Saha, Anagha Kamble, Divya Ramesh Singh, Sivaraj Mohana Sundaram, and Vasudharani Devanathan
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 186
- Publicado: 17 de junio de 2026
- Idioma: Inglés
Sobre el editor
Sobre el editor
SC
Subashchandrabose Chinnathambi
Subashchandrabose Chinnathambi is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau Cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, therapeutic approaches targeting Tau oligomers, and biomarkers for neurodegeneration. He serves on the editorial board for various international cell biology journals and is also a regular invited speaker at a number of meetings and workshops. Dr. Chinnathambi has more than 16 years of research experience in the area of neuroscience and Tau-related research in Alzheimer’s Disease.